94 related articles for article (PubMed ID: 18594168)
1. [Establishment of reference intervals of tumor markers in Korean adults].
Woo HY; Kim YJ; Park H
Korean J Lab Med; 2008 Jun; 28(3):179-84. PubMed ID: 18594168
[TBL] [Abstract][Full Text] [Related]
2. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1.
Yang J; Tang A; Ma J; Sun X; Ming L
Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773
[TBL] [Abstract][Full Text] [Related]
3. Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study.
Bjerner J; Høgetveit A; Wold Akselberg K; Vangsnes K; Paus E; Bjøro T; Børmer OP; Nustad K
Scand J Clin Lab Invest; 2008; 68(8):703-13. PubMed ID: 18609108
[TBL] [Abstract][Full Text] [Related]
4. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
[TBL] [Abstract][Full Text] [Related]
5. [The determination of medical reference values for tumor markers in cerebrospinal fluid].
Shi Q; Pu CQ; Wu WP; Huang XS; Yu SY; Tian CL; Cao XT
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):355-6. PubMed ID: 19563718
[TBL] [Abstract][Full Text] [Related]
6. Establishment and validation of reference intervals for tumor markers (AFP, CEA, CA19-9, CA15-3, CA125, PSA, HE4, Cyfra 21-1, and ProGRP) in primary care centers in Korea: A cross-sectional retrospective study.
Nah EH; Cho S; Park H; Kim S; Kwon E; Cho HI
Health Sci Rep; 2023 Feb; 6(2):e1107. PubMed ID: 36789402
[TBL] [Abstract][Full Text] [Related]
7. [Molecular microheterogeneity of tumor marker substances and its significance of biological recognition].
Kuwabara M; Iwakoshi N; Ariyoshi Y
Nihon Rinsho; 1996 Jun; 54(6):1580-6. PubMed ID: 8691612
[TBL] [Abstract][Full Text] [Related]
8. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
Ma S; Shen L; Qian N; Chen K
Cancer Biomark; 2011-2012; 10(3-4):155-62. PubMed ID: 22674301
[TBL] [Abstract][Full Text] [Related]
9. [Application of multiple tumor markers's protein chip in the screen program of the elderly].
Yan HY; Zhong RH; Li J; Luo XH; Chen R
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Sep; 32(9):924-6. PubMed ID: 22340884
[TBL] [Abstract][Full Text] [Related]
10. The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer.
Wang P; Piao Y; Zhang X; Li W; Hao X
Cancer Biomark; 2013; 13(2):123-30. PubMed ID: 23838141
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
[TBL] [Abstract][Full Text] [Related]
12. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
Chen C; Chen LQ; Yang GL; Li Y
Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
[TBL] [Abstract][Full Text] [Related]
13. [Tumor markers in pleural effusion of patients with lung cancer and patients with tuberculous pleurisy].
Tada A; Kawai H; Matsumoto H; Kimura G; Okada C; Soda R; Takahashi K
Nihon Kokyuki Gakkai Zasshi; 2002 Feb; 40(2):106-12. PubMed ID: 11974864
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
Li CS; Cheng BC; Ge W; Gao JF
Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
[TBL] [Abstract][Full Text] [Related]
15. Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China.
Song WA; Liu X; Tian XD; Wang W; Liang CY; Zhang T; Guo JT; Peng YH; Zhou NK
Chin Med J (Engl); 2011 Oct; 124(20):3244-8. PubMed ID: 22088515
[TBL] [Abstract][Full Text] [Related]
16. Reference intervals for serum alpha-fetoprotein and carcinoembryonic antigen in Chinese Han ethnic males from the Fangchenggang Area Male Health and Examination Survey.
Qin X; Lin L; Mo Z; Lv H; Gao Y; Tan A; Yang X; Li S; Zhao J
Int J Biol Markers; 2011; 26(1):65-71. PubMed ID: 21337313
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of four serological tumor markers for the detection of breast cancer.
Clinton SR; Beason KL; Bryant S; Johnson JT; Jackson M; Wilson C; Holifield K; Vincent C; Hall M
Biomed Sci Instrum; 2003; 39():408-14. PubMed ID: 12724928
[TBL] [Abstract][Full Text] [Related]
18. Reference Intervals of Alpha-Fetoprotein and Carcinoembryonic Antigen in the Apparently Healthy Population.
Zhang GM; Guo XX; Ma XB; Zhang GM
Med Sci Monit; 2016 Dec; 22():4875-4880. PubMed ID: 27941709
[TBL] [Abstract][Full Text] [Related]
19. Serum tumour markers in patients with chronic kidney disease.
Xiaofang Y; Yue Z; Xialian X; Zhibin Y
Scand J Clin Lab Invest; 2007; 67(6):661-7. PubMed ID: 17852811
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen, neuron-specific enolase and creatine kinase-BB as tumor markers for carcinoma of the lung.
Nikliński J; Furman M; Palynyczko Z; Laudański J; Bułatowicz J
Neoplasma; 1991; 38(6):645-51. PubMed ID: 1766488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]